- Home
- PTGX vs NEOG Comparison
PTGX vs NEOG Comparison
Compare PTGX & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- NEOG
- Stock Information
- Founded
- PTGX 2006
- NEOG 1981
- Country
- PTGX United States
- NEOG United States
- Employees
- PTGX N/A
- NEOG N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- NEOG Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- PTGX Health Care
- NEOG Health Care
- Exchange
- PTGX Nasdaq
- NEOG Nasdaq
- Market Cap
- PTGX 2.8B
- NEOG 3.2B
- IPO Year
- PTGX 2016
- NEOG 1989
- Fundamental
- Price
- PTGX $42.97
- NEOG $5.97
- Analyst Decision
- PTGX Strong Buy
- NEOG Buy
- Analyst Count
- PTGX 8
- NEOG 2
- Target Price
- PTGX $66.50
- NEOG $9.00
- AVG Volume (30 Days)
- PTGX 990.2K
- NEOG 7.3M
- Earning Date
- PTGX 05-06-2025
- NEOG 04-09-2025
- Dividend Yield
- PTGX N/A
- NEOG N/A
- EPS Growth
- PTGX N/A
- NEOG N/A
- EPS
- PTGX 0.86
- NEOG N/A
- Revenue
- PTGX $207,801,000.00
- NEOG $905,996,000.00
- Revenue This Year
- PTGX N/A
- NEOG N/A
- Revenue Next Year
- PTGX $7.13
- NEOG $1.40
- P/E Ratio
- PTGX $50.68
- NEOG N/A
- Revenue Growth
- PTGX N/A
- NEOG N/A
- 52 Week Low
- PTGX $24.22
- NEOG $3.87
- 52 Week High
- PTGX $60.60
- NEOG $18.58
- Technical
- Relative Strength Index (RSI)
- PTGX 43.08
- NEOG 48.46
- Support Level
- PTGX $41.29
- NEOG $4.87
- Resistance Level
- PTGX $46.12
- NEOG $6.12
- Average True Range (ATR)
- PTGX 1.83
- NEOG 0.32
- MACD
- PTGX -0.19
- NEOG 0.27
- Stochastic Oscillator
- PTGX 27.81
- NEOG 90.45
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About NEOG Neogen Corporation
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety, Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for maximum revenue, and it also has its presence in United Kingdom and other countries.